Taysha Gene Therapies, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $214.0M
Liabilities Breakdown FY2021
Total Liabilities: $118.6M
Asset Breakdown
Total Assets: $214.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $149.1M | 69.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $50.6M | 23.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $14.2M | 6.7% |
Liabilities Breakdown
Total Liabilities: $118.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $21.8M | 18.4% |
| Long-Term Debt | $37.2M | 31.4% |
| Other Liabilities | $59.6M | 50.3% |